EBV LMP2A antibody
Quick Overview for EBV LMP2A antibody (ABIN472092)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognizes latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV). EBV is a human herpesvirus, which is associated with conditions such as Hodgkin's disease and Burkitt's Lymphoma and is the causative agent in mononucleosis in adolescents. EBV latently infects B lymphocytes. Infected B cells express EBV nuclear antigens and latent proteins LMP1, LMP2A and LMP2B. LMP2A forms aggregates in the plasma membranes of B lymphocytes, where it functions as a negative regulator of the Src and Syk protein tyrosine kinases. Studies show that LMP2A blocks B-cell receptor (BCR) signal transduction in EBV immortalized B cells in vitro and may play an important role in maintaining a latent EBV infection within the peripheral blood B cells of infected individuals. Recognizes LMP2A and does not cross react with LMP2B.
-
Purification
- Affinity purified
-
Immunogen
-
Bacterial TrpE-LMP2A fusion protein.
Type of Immunogen: Fusion protein -
Isotype
- IgG1
-
-
-
-
Application Notes
-
Approved: IHC, IHC-P, WB (1:100 - 1:1000)
Usage: Immunohistology: This product requires antigen retrieval using heat treatment methods prior to staining of paraffin sections. Sodium citrate buffer pH 6.0 is recommended for this purpose. -
Comment
-
Target Species of Antibody: Epstein-Barr Virus
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
-
Short term: -20°C
Long term: -20°C.
-
-
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
-
Alternative Name
- EBV LMP2A
-
Target Type
- Viral Protein
Target
-